Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease

被引：218

作者：

Lefer, AM ^{[1
]}

Scalia, R

Lefer, DJ

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Physiol, Philadelphia, PA 19107 USA

[2] Louisiana State Univ, Med Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71130 USA

来源：

CARDIOVASCULAR RESEARCH | 2001年 / 49卷 / 02期

关键词：

cholesterol; lipid metabolism;

D O I：

10.1016/S0008-6363(00)00247-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：281 / 287

页数：7

共 53 条

[11] HMG CoA reductase inhibition reduces sarcolemmal Na+-K+ pump density [J].

Gray, DF ;

Bundgaard, H ;

Hansen, PS ;

Buhagiar, KA ;

Mihailidou, AS ;

Jessup, W ;

Kjeldsen, K ;

Rasmussen, HH .

CARDIOVASCULAR RESEARCH, 2000, 47 (02) :329-335

[12] MECHANISMS OF VASCULAR PRESERVATION BY A NOVEL NO DONOR FOLLOWING RAT CAROTID-ARTERY INTIMAL INJURY [J].

GUO, JP ;

PANDAY, MM ;

CONSIGNY, PC ;

LEFER, AM .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (03) :H1122-H1131

[13] Direct measurement of nitric oxide release from vascular endothelial cells [J].

Guo, JP ;

Murohara, T ;

Buerke, M ;

Scalia, R ;

Lefer, AM .

JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (02) :774-779

[14] Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels -: Subgroup analyses in the Scandinavian simvastatin survival study [J].

Haffner, SM ;

Alexander, CM ;

Cook, TJ ;

Boccuzzi, SJ ;

Musliner, TA ;

Pedersen, TR ;

Kjekshus, J ;

Pyörälä, K .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (22) :2661-2667

[15] Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells [J].

Hernández-Perera, O ;

Pérez-Sala, D ;

Navarro-Antolín, J ;

Sánchez-Pascuala, R ;

Hernández, G ;

Díaz, C ;

Lamas, S .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2711-2719

[16] Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury [J].

Indolfi, C ;

Cioppa, A ;

Stabile, E ;

Di Lorenzo, E ;

Esposito, G ;

Pisani, A ;

Leccia, A ;

Cavuto, L ;

Stingone, AM ;

Chieffo, A ;

Capozzolo, C ;

Chiariello, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) :214-221

[17] Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions [J].

Kaesemeyer, WH ;

Caldwell, RB ;

Huang, JZ ;

Caldwell, RW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :234-241

[18] A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: Possible relevance of up-regulation of endothelial NO synthase mRNA [J].

Kano, H ;

Hayashi, T ;

Sumi, D ;

Esaki, T ;

Asai, Y ;

Thakur, NK ;

Jayachandran, M ;

Iguchi, A .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) :414-419

[19] Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats [J].

Kimura, M ;

Kurose, I ;

Russell, J ;

Granger, DN .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (08) :1521-1526

[20] Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points [J].

Kinlay, S ;

Selwyn, AP ;

Delagrange, D ;

Creager, MA ;

Libby, P ;

Ganz, P .

CURRENT OPINION IN LIPIDOLOGY, 1996, 7 (06) :389-397

← 1 2 3 4 5 6 →